Synergistic effect of programmed death-1 inhibitor and programmed death-1 ligand-1 inhibitor combined with chemotherapeutic drugs on DLBCL cell lines in vitro and in vivo

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL). Chemotherapy is one of the main treatments for cancer, but the antitumor effect of chemotherapeutic drugs is affected by the patient’s immune status. The programmed cell death 1 (PD-1)/programmed cell death-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Am J Cancer Res
Hauptverfasser: Zhang, Rui, Lyu, Cuicui, Lu, Wenyi, Pu, Yedi, Jiang, Yanyu, Deng, Qi
Format: Artigo
Sprache:Inglês
Veröffentlicht: e-Century Publishing Corporation 2020
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7539778/
https://ncbi.nlm.nih.gov/pubmed/33042618
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge